Louis Theriot
Long Beach, CANPI 1245386358
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $744 and has fallen 61.3% since, to $288 in 2025.
Across 80 payments — averaging $22.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$385
- Corium, LLC$314
- Vertical Pharmaceuticals, LLC$167
- Supernus Pharmaceuticals, Inc.$154
- Sanofi-aventis U.S. LLC$123
- Takeda Pharmaceuticals U.S.A., Inc.$102
- plus $528 from 15 others
What the payments were for
- Food & beverage$1,772100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 18 | $385 |
| Corium, LLC | 13 | $314 |
| Vertical Pharmaceuticals, LLC | 9 | $167 |
| Supernus Pharmaceuticals, Inc. | 6 | $154 |
| Sanofi-aventis U.S. LLC | 4 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $102 |
| Merck | 5 | $92 |
| Neos Therapeutics, LP | 4 | $82 |
| AstraZeneca | 2 | $54 |
| GSK | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Azurity Pharmaceuticals, Inc. | 1 | $32 |
| Alk-abello, Inc | 1 | $29 |
| Sanofi Pasteur Inc. | 2 | $27 |
| Pfizer | 1 | $20 |
| AbbVie | 1 | $19 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Verrica Pharmaceuticals Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.